Status:
COMPLETED
Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
American Foundation for Suicide Prevention
Conditions:
Monopolar Depression, Single Episode or Unspecified
Suicidal and Self-injurious Behaviour
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to combine and adapt Mindfulness-Based Cognitive Therapy (MBCT) + Safety Planning Intervention (SPI) for individuals with suicidal behavior and to determine its feasibilit...
Detailed Description
* The study is a nine-week clinical trial combining Safety Planning Intervention plus Mindfulness-Based Cognitive Therapy for patients with a recent history of suicidal thoughts or behavior and curren...
Eligibility Criteria
Inclusion
- 18-65
- History of depression
- Suicidal behavior or thoughts (i.e., current suicidal thoughts at screening and history of at least one suicide attempt or suicide-related behavior (aborted or interrupted suicide attempt) or suicidal ideation with plan or method in the past 6 months)
- In active treatment (e.g., receiving psychiatric medications)
Exclusion
- Current mania, psychosis, Obsessive-Compulsive Disorder, Traumatic Brain Damage, Organic or Acute Brain Syndrome, Mental Retardation or pervasive developmental disorder
- Requires priority treatment for an acute illness or debilitating problem such as severe primary substance dependence or anorexia nervosa
- Inability to complete psychiatric interview or group treatment due to lack of cooperation or lack of comprehension.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01826240
Start Date
March 1 2013
End Date
February 1 2015
Last Update
December 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University/New York State Psychiatric Institute
New York, New York, United States, 10032